Executive Editor, Generics Bulletin
Informa Pharma Intelligence
As Executive Editor of Generics Bulletin, David Wallace has been writing about the global generics, biosimilars and value-added medicines industries for a decade. Bringing his background and education in law to bear on patent litigation as well as national legislative and regulatory affairs, he also keeps a close eye on corporate strategy, personnel moves, and product pipelines. A regular delegate to industry events and conferences, he maintains close links with national and international representatives of the off-patent industry. He also organizes and judges the annual Global Generics & Biosimilars Awards.